Name: 15th World Congress on Hematology and Oncology
Start: 2023-11-09
End: 2023-11-11
Location: singapore

Conference Information

Welcome Message

The organizing committee for the Hematology Congress 2023 is pleased to welcome you to participate in the "15th World Congress on Hematology and Oncology," which will be held on November 9–11, 2023, in Singapore.

This conference is considered to be the most significant and perfect platform for all researchers, hematologists, oncologists, physicians, surgeons, nurses, scientists, business experts, and students who are all interested in the field of hematology.

This conference aims to provide a unique theme: "Integrating New Ideas and Analyzing Innovative Hematology Concepts."

The conference will be organized around several keynote addresses, symposiums, workshops, oral presentations, and posters where attendees will have the chance to interact with global leaders in academic and corporate diagnostic imaging and therapeutic research communities and gain knowledge from experts. The scientific conference offers a wide range of members of the hematology community an outstanding opportunity to address the issues surrounding blood disorders.

Researchers from different institutions will exchange their ideas and discuss topics that include patient management and care, developing hematology techniques, and advancements in the field to diagnose and treat hematologic disorders, among many other things.

We anticipate Hematology 2023 to be a very dynamic and welcoming organization where you will join us and discover it to be an exciting time for future developments.

Sessions/Tracks

TRACK-1: HEMATOLOGY

Hematology is the branch of medicine that deals with the study, diagnosis, treatment, and prevention of diseases related to blood and blood-forming tissues. Recent research in hematology has focused on the development of new diagnostic and treatment approaches to improve patient outcomes. Advances in genomics have allowed for the development of personalized treatment plans based on a patient's unique genetic makeup. This approach has been applied to the treatment of hematological cancers such as leukemia, lymphoma, and multiple myeloma.

Immunotherapy is a treatment that uses the body's immune system to fight cancer. Recent research has shown that immunotherapy can be effective in treating hematological cancers, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, and multiple myeloma. Gene therapy involves the modification of a patient's DNA to treat or cure a disease. In hematology, gene therapy has been used to treat inherited blood disorders such as sickle cell anemia and thalassemia.

Liquid biopsies involve the analysis of a patient's blood to detect cancer or monitor cancer treatment. Recent research has shown that liquid biopsies can be used to diagnose and monitor hematological cancers, including leukemia and lymphoma. Targeted therapies are drugs that are designed to target specific proteins or genes involved in the development of cancer. Recent research has led to the development of targeted therapies for hematological cancers, including chronic myeloid leukemia and lymphoma.

Recent advances in hematology research are providing new opportunities for the diagnosis and treatment of hematological diseases, leading to improved outcomes for patients.

Hematopathology
Transfusion Medicine
Hemostasis and Thrombosis
Pediatric Hematology/Oncology
Hematopoietic Stem Cell Transplantation

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

American Society of Hematology | Hematology/Oncology Pharmacy Association | The European Hematology Association | The American Society of Pediatric Hematology/Oncology | Singapore Society of Hematology | Austrian Society of Hematology and Oncology | International Society of Blood Transfusion | Brazilian Association of Hematology | Mexican Society of Blood Transfusion | International Association of Asia-Pacific Blood Types and Genomics | International Society on Thrombosis and Hemostasis | British Society for Haematology | Association of Veterinary Hematology and Transfusion Medicine.

RELATED JOURNALS:

TRACK-2: ONCOLOGY

Oncology is the branch of medicine that deals with the research, diagnosis, treatment, and fight against cancer. Recent research in oncology has focused on a variety of approaches to improve the diagnosis, treatment, and prevention of cancer.

Advances in the genomic analysis have enabled researchers to identify genetic mutations and alterations in cancer cells that can be targeted by specific treatments. This approach has led to the development of precision medicine approaches for the treatment of cancer. Immunotherapy is a treatment that uses the body's immune system to fight cancer. Recent research has focused on the development of new immunotherapy treatments, such as checkpoint inhibitors and CAR-T cell therapy that can be effective in treating various types of cancer.

Targeted therapies are drugs that are designed to target specific proteins or genes involved in the development of cancer. Recent research has led to the development of targeted therapies for various types of cancer, including breast cancer, lung cancer, and melanoma.

Liquid biopsies involve the analysis of a patient's blood to detect cancer or monitor cancer treatment. Recent research has shown that liquid biopsies can be used to diagnose and monitor various types of cancer, including lung cancer, breast cancer, and colon cancer. Artificial intelligence and machine learning techniques are being applied to oncology research to help improve cancer diagnosis, treatment, and prevention. These techniques can be used to analyze large datasets of patient information and develop more accurate predictive models for cancer.

Recent research in oncology is leading to the development of new approaches and treatments that have the potential to improve patient outcomes and save lives.

Medical Oncology
Surgical Oncology
Radiation Oncology
Pediatric Oncology
Palliative Care and Oncology

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-3: BLOOD CANCER

Blood cancer, also known as hematological malignancy, refers to a group of cancers that affect the blood, bone marrow, and lymphatic system. Recent research in blood cancer has focused on developing new approaches to improve the diagnosis, treatment, and prevention of these diseases. Immunotherapy is a kind of cancer treatment that uses the body's immune system to fight against cancer. Recent research has shown that immunotherapy can be effective in treating blood cancers such as leukemia, lymphoma, and multiple myeloma.

CAR-T cell therapy is a type of immunotherapy that involves genetically modifying a patient's T cells to target cancer cells. Recent research has shown that CAR-T cell therapy can be effective in treating blood cancers such as leukemia and lymphoma. Advances in genomic analysis have enabled researchers to identify genetic mutations and alterations in blood cancer cells that can be targeted by specific treatments. This approach has led to the development of precision medicine approaches for the treatment of blood cancers.

Gene therapy involves the modification of a patient's DNA to treat or cure a disease. Recent research has led to the development of gene therapy approaches for the treatment of blood disorders such as sickle cell anemia and thalassemia. Targeted therapies are drugs that are designed to target specific proteins or genes involved in the development of cancer. Recent research has led to the development of targeted therapies for blood cancers such as chronic myeloid leukemia and lymphoma.

Hematological Malignancies
Hematopoietic Stem Cell Transplantation
Hematopathology
Immunotherapy
Precision Medicine

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-4: ANEAMIA AND LEUKEMIA

Anemia and leukemia are two types of blood disorders that can have significant impacts on a patient's health. Recent research in these areas has focused on developing new techniques and a treatment to improve patient outcomes. Stem cell transplantation involves replacing a patient's diseased bone marrow with healthy stem cells. Recent research has focused on improving the success rates of stem cell transplantation for the treatment of leukemia and other blood disorders.

Gene therapy involves the modification of a patient's DNA to treat or cure a disease. Recent research has led to the development of gene therapy approaches for the treatment of anemia and leukemia. For example, gene therapy is being studied as a potential treatment for sickle cell anemia. Targeted therapies are drugs that are designed to target specific proteins or genes involved in the development of cancer. Recent research has led to the development of targeted therapies for leukemia, such as tyrosine kinase inhibitors for chronic myeloid leukemia.

Anemia is often treated with iron supplements. Recent research has focused on improving the effectiveness of iron supplementation for the treatment of anemia.

Myelodysplastic Syndromes
Acute Lymphoblastic Leukemia.
Chronic Lymphocytic Leukemia
Acute Myeloid Leukemia
Chronic Myeloid Leukemia

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-5: CRYOGLOBULINEMIA

Cryoglobulinemia is a rare condition in which abnormal proteins called cryoglobulins circulate in the blood and cause inflammation and damage to blood vessels and organs. Recent research in cryoglobulinemia has focused on developing new approaches for diagnosis, treatment, and management of the condition. Targeted therapies are drugs that are designed to target specific proteins or genes involved in the development of a disease. Recent research has led to the development of targeted therapies for cryoglobulinemia, such as rituximab, which is an antibody that targets B cells.

Immunomodulatory therapy involves the use of drugs that regulate the immune system. Recent research has shown that immunomodulatory therapy can be effective in treating cryoglobulinemia, such as the use of interferon-alpha. Plasmapheresis is a process in which the patient's blood is filtered to remove the cryoglobulins. Recent research has shown that plasmapheresis can be effective in managing the symptoms of cryoglobulinemia.

Recent research has focused on developing new diagnostic tools for cryoglobulinemia, such as the use of advanced imaging techniques like magnetic resonance imaging (MRI) and ultrasound. Recent research has shown that a combination of different treatment approaches can be effective in managing cryoglobulinemia, such as combining plasmapheresis with immunomodulatory therapy.

Rheumatology
Hematology
Immunology
Nephrology
Infectious Diseases

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-6: STEM CELLS TRANSPLANTATION

Stem cell transplantation, also known as hematopoietic stem cell transplantation (HSCT), is a medical procedure that involves the transplantation of stem cells to replace damaged or diseased cells in the body. The use of gene editing technologies such as CRISPR/Cas9 to modify stem cells before transplantation has shown promise in treating genetic disorders such as sickle cell anemia.

Mesenchymal stem cells (MSCs) are a type of adult stem cell that can differentiate into a variety of cell types, including bone, cartilage, and fat. Recent studies have shown that MSCs can also modulate the immune system, making them a potential treatment option for autoimmune diseases. Induced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to become stem cells. Recent research has focused on using iPSCs to develop personalized treatments for diseases such as Parkinson's and diabetes.

Umbilical cord blood contains stem cells that can be used to treat a variety of diseases, including leukemia and other blood disorders. Recent advances in cord blood banking and transplantation techniques have made this procedure more widely available. Tissue engineering involves the use of stem cells to create new tissues and organs. Recent research has focused on using stem cells to develop functional organs such as the heart, liver, and kidneys.

Transplantation Medicine
Hematopoietic Stem Cell Transplantation
Cellular Therapy
Regenerative Medicine

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-7: PROGNOSIS

Prognosis is the prediction of the likely course or outcome of a disease or condition. There have been several recent research and approaches that are improving the accuracy of prognosis, including: Machine learning algorithms can analyze large amounts of data to identify patterns and predict outcomes. Recent studies have shown that machine learning algorithms can accurately predict the prognosis of patients with cancer, heart disease, and other conditions.

Liquid biopsy is a non-invasive test that analyzes blood or other bodily fluids to detect cancer or other diseases. Recent research has shown that liquid biopsy can be used to monitor disease progression and predict prognosis in patients with cancer. Biomarkers are molecules or substances that can be used to indicate the presence or severity of a disease. Recent research has identified several biomarkers that can be used to predict the prognosis of patients with cancer, heart disease, and other conditions.

Personalized medicine involves tailoring treatment to the individual characteristics of each patient, including their genetics, lifestyle, and environment. Recent research has shown that personalized medicine can improve the accuracy of prognosis and lead to better outcomes for patients with cancer, heart disease, and other conditions. Telemedicine involves using technology such as video conferencing to provide remote medical care. Recent research has shown that telemedicine can improve the accessibility of medical care and lead to better outcomes for patients with chronic conditions.

Genetics
Epidemiology
Psychiatry
Emergency Medicine
Geriatrics

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-8: CERVICAL CANCER

Cervical cancer affects the cells of the cervix, which is the bottom portion of the uterus. There have been several recent research approaches to cervical cancer, including: Human papillomavirus (HPV) is a common sexually transmitted infection that can cause cervical cancer. HPV vaccines can prevent infection with certain strains of the virus and have been shown to be highly effective in preventing cervical cancer.

Liquid biopsy is a non-invasive test that analyzes blood or other bodily fluids to detect cancer or other diseases. Recent research has shown that liquid biopsy can be used to detect early-stage cervical cancer and monitor disease progression. Immunotherapy involves using the body's immune system to fight cancer. Recent research has focused on using immunotherapy to treat cervical cancer, including the development of vaccines that target cancer-specific antigens.

Precision medicine involves tailoring treatment to the individual characteristics of each patient, including their genetics, lifestyle, and environment. Recent research has shown that precision medicine can improve the accuracy of diagnosis and lead to better outcomes for patients with cervical cancer. Regular screening for cervical cancer, such as Pap tests and HPV testing, can detect abnormal cells before they become cancerous. Recent research has focused on improving the accuracy of screening tests and increasing access to screening for underserved populations.

Gynecologic Oncology
Radiation Oncology
Surgical Oncology
Medical Oncology
Colposcopy
Reproductive Health

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-9: IRON METABOLISM DISORDERS

Iron metabolism disorders refer to conditions in which the body is unable to properly regulate the absorption, transport, and storage of iron. Iron metabolism disorders such as hemochromatosis can be caused by genetic mutations. Genetic testing can identify individuals who are at risk of developing these conditions and help guide treatment and management.

Imaging tests such as magnetic resonance imaging (MRI) can be used to evaluate the extent of iron overload in the body, which is a hallmark of iron metabolism disorders such as hemochromatosis. Biomarkers such as serum ferritin and transferrin saturation can be used to assess the iron status and diagnose iron metabolism disorders.

Iron chelation therapy involves using drugs that bind to excess iron in the body and helps remove it from the system. Recent research has focused on developing new iron-chelating agents and improving the efficacy and safety of existing therapies. Nutritional interventions such as iron supplementation and dietary modification can be used to manage iron metabolism disorders. Recent research has focused on identifying the optimal dosages and formulations of iron supplements and developing dietary guidelines for individuals with iron metabolism disorders.

Hematology
Genetics
Oncology
Pediatrics
Immunology
Nutritional Sciences

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-10: CHEMOTHERAPY

Chemotherapy is a widely used cancer treatment that involves the use of drugs to kill cancer cells. Over the years, there have been many advances in chemotherapy research, leading to the development of new and more effective treatments. Targeted therapy is a type of chemotherapy that specifically targets cancer cells without harming healthy cells. It works by using drugs that target specific proteins or enzymes that are overexpressed in cancer cells. This approach has been shown to be highly effective in treating certain types of cancer, such as breast, lung, and colorectal cancer.

Immunotherapy is a type of chemotherapy that uses the body's immune system to fight cancer. It works by stimulating the immune system to recognize and attack cancer cells. This approach has been shown to be effective in treating certain types of cancer, such as melanoma, lung cancer, and kidney cancer. Nanoparticle-based chemotherapy involves the use of tiny particles to deliver chemotherapy drugs directly to cancer cells. This approach has been shown to be highly effective in treating certain types of cancer, such as ovarian cancer and pancreatic cancer.

Combination therapy involves the use of multiple chemotherapy drugs in combination to increase their effectiveness. This approach has been shown to be highly effective in treating certain types of cancer, such as breast cancer and lung cancer. Personalized medicine involves the use of genetic testing to identify specific mutations in a patient's cancer cells. This information can be used to develop a personalized treatment plan that is tailored to the individual patient's needs. This approach has been shown to be highly effective in treating certain types of cancer, such as lung cancer and melanoma.

Medical Oncology
Radiation Oncology
Pharmacology
Clinical Trials
Pediatric Oncology
Oncology Nursing
Integrative Oncology

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-11: SURGICAL ONCOLOGY

Surgical oncology is a specialized field of surgery that focuses on the surgical management of cancer. Recent research in surgical oncology has focused on improving surgical techniques, minimizing complications, and optimizing patient outcomes. Minimally invasive surgery is a surgical technique that uses small incisions and specialized instruments to perform surgery. Recent research has shown that minimally invasive surgery can be used to safely and effectively treat certain types of cancer, such as prostate cancer and colorectal cancer.

Robotic surgery is a type of surgery that is minimally invasive that implements robotic arms to carry out the operation. Recent research has shown that robotic surgery can be used to safely and effectively treat certain types of cancer, such as prostate cancer, kidney cancer, and gynecologic cancers. Enhanced recovery after surgery is a multimodal approach to surgical care that aims to optimize patient outcomes by minimizing surgical stress and reducing complications. Recent research has shown that ERAS protocols can be used to improve outcomes for patients undergoing surgery for cancer.

Sentinel lymph node biopsy is a surgical technique that involves removing the first lymph node(s) that cancer is likely to spread to from the primary tumor. Recent research has shown that sentinel lymph node biopsy can be used to safely and accurately stage certain types of cancer, such as breast cancer and melanoma. Perioperative care refers to the care that a patient receives before, during, and after surgery. Recent research has shown that optimizing perioperative care can improve outcomes for patients undergoing surgery for cancer, such as reducing complications and improving quality of life.

Breast Surgery
Gynecologic Surgery
Orthopedic Oncology
Pediatric Surgery
Surgical Oncology Research

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-12: BLOOD DISORDERS

Blood disorders refer to a wide range of conditions that affect the blood and blood-forming tissues, including red blood cells, white blood cells, and platelets. Recent scientific research in blood disorders has focused on developing new treatments, improving diagnosis and monitoring, and enhancing our understanding of the underlying mechanisms of these conditions. Gene therapy has the potential to be an effective treatment option for blood disorders. Recent research has focused on using gene therapy to treat inherited blood disorders, such as sickle cell anemia and thalassemia. This approach involves introducing a functional copy of the affected gene into the patient's cells to restore normal function.

Chimeric antigen receptor (CAR) T-cell therapy is a new form of immunotherapy that has shown promise in the treatment of blood disorders, particularly certain types of leukemia and lymphoma. CAR-T therapy involves modifying a patient's own T-cells to recognize and attack cancer cells. Liquid biopsies are a non-invasive way to detect and monitor blood disorders. Recent research has focused on using liquid biopsies to monitor response to treatment, detect disease recurrence, and identify potential targets for therapy.

Precision medicine involves tailoring treatment to the individual patient's specific genetic and molecular profile. Recent research has focused on using precision medicine approaches to develop targeted therapies for blood disorders, particularly leukemia and lymphoma. Artificial intelligence (AI) has shown promise in improving the diagnosis and treatment of blood disorders. Recent research has focused on using AI algorithms to analyze large amounts of data and identify patterns that could help predict disease progression, response to treatment, and potential complications. These advances have the potential to improve outcomes for patients with blood disorders and ultimately lead to better quality of life.

Hematology
Hemophilia and Bleeding Disorders
Thrombosis and Hemostasis
Pediatric Hematology-Oncology
Hemoglobinopathies

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-13: BLOOD CLOTTING DISORDERS

Blood clotting disorders refer to conditions where the body's blood clotting system is impaired, leading to abnormal bleeding or clotting. Recent research in this field has focused on understanding the underlying mechanisms of these conditions, improving diagnosis and treatment, and developing new therapies. COVID-19 is a viral infection that has been associated with blood clotting disorders. Recent research has shown that COVID-19 can cause abnormal clotting in the lungs, leading to a condition called pulmonary embolism, and may also increase the risk of stroke in some patients. Understanding the mechanisms of these clotting disorders and developing effective treatments is an important area of research.

Anticoagulants are drugs that prevent blood clots from forming or getting larger. Recent research has focused on developing new anticoagulants that are more effective and have fewer side effects than existing drugs, such as warfarin. These new drugs, such as apixaban and rivaroxaban, have shown promise in preventing blood clots in patients with atrial fibrillation and other conditions. Genetic testing can help identify inherited clotting disorders, such as factor V Leiden thrombophilia and protein C deficiency. Recent research has shown that genetic testing can be used to identify individuals who are at increased risk of developing blood clots and help guide their treatment.

Thrombophilia is a genetic condition that increases the risk of blood clots. Recent research has focused on developing new therapies for thrombophilia, such as gene therapy and monoclonal antibodies that target specific clotting factors. Bleeding disorders, such as hemophilia and von Willebrand disease, are conditions where the blood does not clot properly, leading to excessive bleeding. Recent research has focused on developing new therapies for these conditions, such as gene therapy and factor replacement therapy, which can help improve quality of life for patients.

Bleeding Disorders
Thrombophilia
Anticoagulation
Platelet Disorders
Vascular Medicine
Interventional Hematology
Thromboembolism

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-14: ONCOGENESIS

Oncogenesis refers to the process of cancer development, including the initiation, progression, and metastasis of cancer cells. Genomics and epigenomics are powerful tools for studying the molecular mechanisms of cancer development. Recent research has focused on using these techniques to identify new cancer drivers, such as mutations in oncogenes and tumor suppressor genes, and to develop targeted therapies for specific cancer types.

Immunotherapy is a new class of cancer treatment that harnesses the body's immune system to fight cancer cells. Recent research has focused on developing new immunotherapies, such as immune checkpoint inhibitors and chimeric antigen receptor (CAR) T-cell therapy, which have shown promising results in the treatment of certain types of cancer. Single-cell sequencing is a technique that allows researchers to study the genetic and molecular profiles of individual cells. Recent research has focused on using single-cell sequencing to identify rare cell populations within tumors that may be responsible for driving cancer growth and to develop new therapies that target these cells.

Liquid biopsies are a non-invasive way to detect and monitor cancer. Recent research has focused on using liquid biopsies to identify biomarkers of cancer progression and response to treatment, as well as to develop new therapies that target these biomarkers. Artificial intelligence (AI) is a powerful tool for analyzing large amounts of data and identifying patterns that may be difficult to detect using traditional methods. Recent research has focused on using AI algorithms to analyze genomics and imaging data to identify new cancer drivers and develop personalized treatment strategies.

Cancer genetics
Cancer diagnostics
Cancer therapeutics
Cancer stem cells
Metastasis
Precision oncology

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-15: PEDIATRIC BLOOD DISORDERS

Pediatric blood disorders encompass a wide range of conditions that affect the production, function, and circulation of blood cells in children. Recent research approaches in the field of pediatric hematology have focused on Precision medicine is an emerging approach that aims to tailor medical treatment to the individual characteristics of each patient, such as their genetic makeup, environmental factors, and lifestyle. In pediatric hematology, precision medicine is being used to identify genetic mutations and biomarkers associated with specific blood disorders, which can help in developing targeted therapies that are more effective and have fewer side effects.

Gene therapy involves the insertion of healthy genes into a patient's cells to correct or replace the faulty genes that cause certain genetic disorders. In pediatric hematology, gene therapy has shown promising results for the treatment of rare blood disorders, such as severe combined immunodeficiency (SCID) and thalassemia. Immunotherapy involves the use of drugs or other substances to stimulate or suppress the immune system to fight or prevent disease. In pediatric hematology, immunotherapy is being explored as a potential treatment for leukemia and other blood cancers.

Stem cell transplantation involves the transfer of stem cells from a donor to a recipient to replace damaged or diseased cells in the body. In pediatric hematology, stem cell transplantation is used to treat a range of blood disorders, including leukemia, sickle cell disease, and thalassemia. Artificial intelligence (AI) is being used to analyze large amounts of data from patients with pediatric blood disorders to identify patterns and potential treatment options. AI is also being used to develop predictive models for the long-term outcomes of these disorders, which can help in developing personalized treatment plans and improving patient outcomes.

Immune thrombocytopenia
Anemia
Bone marrow failure syndromes
Thrombotic disorders
Transfusion medicine
Clinical research

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-16: CLINICAL HEMATOLOGY

Clinical hematology is the study and treatment of diseases of the blood and blood-forming tissues. Hematology diseases may involve: blood cells (red blood cells, white blood cells, and platelets); other blood components; The organs of hematopoiesis (bone marrow, lymph nodes, spleen). Precision medicine is an approach that involves tailoring medical treatments to individual patients based on their genetic makeup, lifestyle, and environment. In the field of hematology, precision medicine is being used to develop targeted therapies for blood disorders such as leukemia and lymphoma.

In the field of hematology, immunotherapy is being used to develop new treatments for blood cancers such as multiple myeloma and lymphoma. Stem cell transplantation is a procedure in which healthy stem cells are transplanted into a patient's bone marrow to replace damaged or diseased cells. Recent research in this field has focused on improving the success rate of stem cell transplantation and reducing the risk of complications.

Biomarkers are molecules that can be used to diagnose and monitor disease. In the field of hematology, researchers are actively working to identify new biomarkers that can be used to improve diagnosis and treatment of blood disorders. Artificial intelligence (AI) is being used in the field of hematology to develop new diagnostic tools and treatment strategies. For example, AI algorithms can be used to analyze large amounts of patient data to identify patterns and predict outcomes.

Anemia
Hemostasis and thrombosis
Hematologic malignancies
Blood transfusion
Stem cell transplantation
Coagulation disorders

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-17: ONCOLOGY PHARMACY

Oncology Pharmacy provides cancer patients with evidence-based, patient-centered medication therapy management and directs patient care, including treatment assessment and monitoring for potential adverse drug reactions and interactions. Researchers are developing targeted drug delivery systems that can deliver cancer drugs directly to tumors, while sparing healthy cells. This approach could potentially reduce side effects and improve treatment outcomes.

Immunotherapy is an emerging field in oncology that involves using the patient's immune system to fight cancer. Recent studies have focused on developing new immunotherapies, improving existing therapies, and identifying biomarkers that can predict response to treatment. Personalized medicine is an approach that involves tailoring medical treatments to individual patients based on their genetic makeup, lifestyle, and environment. In oncology pharmacy, personalized medicine is being used to develop targeted therapies for specific types of cancer, such as lung cancer and melanoma.

Combination therapy involves using multiple drugs or treatments to attack cancer cells from different angles. Recent research has focused on identifying the most effective combinations of drugs, and on developing new drugs that can be used in combination therapy. Drug resistance is a major challenge in oncology pharmacy, as cancer cells can become resistant to chemotherapy and other treatments. Recent studies have focused on understanding the mechanisms of drug resistance and on developing new strategies to overcome it, such as using combination therapy and immunotherapy.

Chemotherapy
Targeted therapies
Immunotherapy
Oncology compounding
Pediatric oncology
Palliative care
Oncology pharmacy administration

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

TRACK-18: SEPSIS BLOOD DISEASE

Sepsis is a potentially life-threatening blood disease that occurs when the body's response to an infection becomes dysregulated, leading to inflammation and organ dysfunction. Early detection and diagnosis of sepsis is crucial for improving patient outcomes. Recent research has focused on developing new biomarkers and diagnostic tools that can identify sepsis early and accurately.

Precision medicine is an approach that involves tailoring medical treatments to individual patients based on their genetic makeup, lifestyle, and environment. In the field of sepsis, precision medicine is being used to develop personalized treatment plans based on the patient's specific immune response and genetic profile. Immunomodulation is a treatment approach that involves modulating the immune response to prevent or treat sepsis. Recent studies have focused on developing new immunomodulatory drugs and therapies, such as cytokine inhibitors and monoclonal antibodies.

Antibiotic stewardship involves the responsible use of antibiotics to prevent antibiotic resistance and improve patient outcomes. Recent research has focused on developing new strategies for antibiotic stewardship in the context of sepsis, such as using rapid diagnostic tests to guide antibiotic selection. Big data and machine learning are being used to analyze large amounts of patient data and identify patterns that can help predict and prevent sepsis. For example, machine learning algorithms can be used to analyze electronic health records to identify patients at high risk for sepsis and develop personalized treatment plans.

Hematopathology
Hemoglobinopathies
Hematologic malignancies
Hematopoietic stem cell transplantation
Hematology nursing
Hematology research

RELATED CONFERENCES:

RELATED ASSOCIATION AND SOCIETIES:

RELATED JOURNALS:

Market Analysis

According to the most recent Reports and Data report, the global hematology diagnostics market is expected to reach USD 5,758.6 million in 2030, with revenue CAGR of 4.9% during the forecast period. Demand for hematological diagnostics is expected to rise as healthcare providers and patients become more aware of blood disorders, driving market revenue growth over the forecast period.

The rising prevalence of blood cancers such as leukemia, as well as rising demand for early diagnosis and treatment monitoring, are major factors driving market revenue growth.

The Asia-Pacific market is projected to increase at the rapid speed in the worldwide market during the forecast period. Rapid population growth, rising prevalence of chronic diseases such as cancer and hematological diseases, particularly in developing countries such as India and China, and improved healthcare infrastructure are some of the major factors driving revenue growth in the Asia-Pacific market. Each year, over 1.1 million cancer cases are recorded in India, according to the Central Institute of Preventing Cancer and Experiments. As a result, the region's high cancer prevalence is expected to drive up demand for hematology diagnostics in Asia-Pacific.

Abbott Laboratories, Beckman Coulter, Inc., Ortho Clinical Diagnostics, Siemens Healthcare, Biotech Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Mindray Medical International Limited, Drew Scientific Inc., Bio-Rad Laboratories Inc., HemoCue AB, Horiba Ltd., EKF Diagnostics, and Nihon Kohden Corporation are among the key market companies that operate in the international market. To enhance their market position and expand revenue shares, major market players are concentrating on different tactics such as new product launches, capital investments, and partnerships.

FORECAST FOR THE REGION (REVENUE, USD MILLION, 2019 - 2030):

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
Africa
Rest of Middle East And Africa

MARKET ANALYSIS OF STEM CELLS TRANSPLANTATION

The global stem cell therapy market was estimated to be worth $205.1 million in 2021 and is expected to be worth $928.6 million by 2031, growing at a CAGR of 16.2% between 2022 and 2031. Stem cells are the raw materials from which all other cells with specialized functions are generated in the body. Stem cell therapy, also known as gene therapy, enhances the repair response of infected, inadequate, or wounding tissue by using stem cells or their derivatives. It is the next step in organ transplantation and uses cells rather than donor organs, which are in short supply. In a laboratory, stem cells are grown. These stem cells are programmed to become specific types of cells, such as heart muscle cells and blood cells. The cells may also be implanted into people. If the individual has cardiovascular disease, the cells could be induced into the heart muscle. The healthy heart muscle cells that were transplanted could then help to repair the injured heart muscle. Stem cells are replaced with damaged cells by chemotherapy or serve as a way for the donor's immune system to fight certain types of cancer and blood-related diseases such as leukemia, lymphoma, neuroblastoma, and multiple myeloma. In these transplants, mature stem cells or blood from the umbilical cord are used.

The stem cell therapy market is divided into three sections: Cell Source, Application, and Type. The market is divided into three sections based on cell source: adipose tissue-derived mesenchymal stem cells, bone marrow-derived mesenchymal stem cells, cord blood/embryonic stem cells, and other cell sources. Cancer, musculoskeletal disorders, wounds and injuries, cardiovascular diseases, gastrointestinal diseases, and other applications comprise the market. The market is divided into two types: allogeneic transplants and autologous transplants. Furthermore, allogeneic transplants are divided into pediatric and adult categories. Also, autologous transplants are divided into pediatric and adult categories. The market is studied across North America (the United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and the Rest of Asia-Pacific), and Latin America (LAMEA) (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

MARKET ANALYSIS OF ONCOLOGY

Oncology is a rapidly growing field in Singapore, with a focus on cancer diagnosis, treatment, and research. The country is home to some of the world's leading cancer research institutions and hospitals, making it a hub for oncology research and treatment.

MARKET SIZE AND TRENDS:

The oncology market in Singapore is expected to grow steadily in the coming years, driven by factors such as increasing cancer incidence rates and gro wing healthcare expenditure. According to a report by Grand View Research, the oncology market in Singapore is expected to reach USD 2.5 billion by 2025, growing at a CAGR of 7.5% from 2020 to 2025.

MARKET SEGMENTATION:

The oncology market in Singapore can be segmented into various categories, such as cancer type, treatment type, and end-user. The cancer type segment can be further divided into lung cancer, breast cancer, colorectal cancer, prostate cancer, and others. The treatment type segment can be divided into chemotherapy, immunotherapy, radiation therapy, and others. The end-user segment can be divided into hospitals, cancer research centers, and others.

KEY PLAYERS:

Some of the key players in the oncology market in Singapore include National Cancer Centre Singapore, Singapore General Hospital, Parkway Cancer Centre, Mount Elizabeth Hospital, and Raffles Hospital. These institutions offer a range of cancer treatment options and are renowned for their research and development efforts in the field of oncology.

CHALLENGES:

Despite the growing oncology market in Singapore, there are some challenges that need to be addressed. These include the high cost of cancer treatment, shortage of skilled healthcare professionals, and limited access to cancer treatment in remote areas. The oncology market in Singapore is expected to grow in the coming years, driven by increasing cancer incidence rates and growing healthcare expenditure. The country is home to some of the world's leading cancer research institutions and hospitals, making it a hub for oncology research and treatment. However, challenges such as the high cost of cancer treatment and shortage of skilled healthcare professionals need to be addressed to ensure that patients receive timely and affordable cancer care.

About Conference

The board of Hematology 2023 is pleased to invite you to the upcoming "15th World Congress on Hematology and Oncology," which will be held in Singapore on November 9-11, 2023. This congress is expected to be the most important and excellent great hall for all, Hematologists, Scientists Pathologists, Nurses, Oncologists, Research Scholars, Surgeons, Business Professionals, and Students working in the field of Hematology.

"Integrating New Ideas and Analyzing Innovative Hematology Concepts" is the theme of the hematology 2023 congress.

Hematology Congress 2023 features oral discussions with speakers, Keynote speakers, eminent persons, Studios, and shows. Here, scientific researchers and associations will exchange ideas and discuss Patient Management and Care, new methodologies emerging in Hematology and advanced procedures for the diagnosis and treatment of both hematologic and oncologic disorders.

WHY TO JOIN THE EVENT?

Hematology Congress 2023 will provide a rational environment and a stage for members to exchange their perspectives and ideas on Hematology research and cancer research. G20 Countries Experts and associations from around the world focused on learning about Cancer, Hemophilia, Blood Coagulation, and Hematologic Oncology can participate in a collaborative effort and system administration; an extraordinary opportunity to bring together a massive array of members from the Hematology people group to battle against such serious risks.

TARGET AUDIENCE

Hematologists
Oncologists
Hematopathologists
Scientists
Young Researchers
Medical Students
Physicians/Consultants/ General Practitioners
Nurses
Residents
Directors/Managers
Pathologists
Presidents and Vice Presidents/Directors/Administrators
Business Entrepreneurs
Hematology Pharma Companies
Medical Devices Companies
Hematology Associations/ Societies.

BENEFITS OF HEMATOLOGY 2023:

FOR YOUNG RESEARCHERS:

Abstracts accepted will be published in one of our highly indexed supporting journals
Global collaboration

FOR SPONSERS AND EXHIBITORS:

Advertisers and Sponsors have a one-of-a-kind opportunity

FOR OCM:

It will be encouraged to provide a platform for organizing Symposia or Workshops/Symposia on new research topics.
Special interactive session will be provided if you are coming with your research team

FOR SPEAKERS: